CHICAGO–(BUSINESS WIRE)–Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today provided comments on the passage of the Secure and Fair Enforcement Banking Act of 2019 (“SAFE Banking Act.”) “The passage of the SAFE Banking Act by the U.S.…
DetailsNEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Sundial Growers Inc. (NASDAQ:SNDL) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Sundial’s August 1, 2019 initial public…
DetailsSAN DIEGO–(BUSINESS WIRE)–Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (NYSE: IIPR) focused on the regulated U.S. cannabis industry, announced today that it entered into amendments of the lease and development agreement with a subsidiary of PharmaCann LLC (PharmaCann) at the property located at 465…
DetailsTORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today provides a statement regarding DabTabsTM technology, certifications, and 3rd party testing reinforcing that DabTabsTM are fundamentally different to current vaporization technologies. DabTabsTM provide consumers with a different vaporization experience. DabTabsTM are manufactured in the United States, in an ISO 9000-2015…
DetailsMALIBU, Calif.–(BUSINESS WIRE)–Green Gorilla™, a leading manufacturer and brand of cannabidiol (CBD) products, received the highest possible score of “A” in a just-released independent study of CBD products from the nonprofit watchdog Center for Food Safety. Green Gorilla™ was one of only four companies to receive a grade of “A,” with more than half of…
DetailsPARSIPANNY, N.J. & SEATTLE–(BUSINESS WIRE)–Hudson News Distributors and Docklight Brands, a pioneering consumer brand company, today announced a distribution agreement under which Hudson News Distributors will make Docklight’s portfolio of hemp-derived CBD-infused products available to retailers across the Northeast U.S. The agreement between Hudson News Distributors and Docklight Brands provides an end to end supply…
DetailsWASHINGTON–(BUSINESS WIRE)–New Frontier Data, the authority in data, analytics and business intelligence for the global cannabis industry, in collaboration with Vote Hemp, releases The U.S. Hemp Market: 2019 State Rankings. The report examines the current state of hemp cultivation in the United States. Findings include analysis of individual market’s licensee landscape as well as predictions…
DetailsSAN FRANCISCO–(BUSINESS WIRE)–PAX Labs, Inc., a leading consumer technology brand in cannabis, today announced the formation of a health advisory board. Composed of highly respected experts across immunology, cannabis research and patient safety, this board underscores PAX’s commitment to consumer health. The board will meet quarterly and advise on key areas including vaporization safety, mental…
DetailsSAN DIEGO–(BUSINESS WIRE)–CB Therapeutics is a leading synthetic biotechnology company focused on the research and development of cellular agriculture for the production of high-value molecules, compounds and rare ingredients. CB Therapeutics has developed a patent-pending platform for creating and annotating libraries of biosynthetic pathway genes from next generation sequencing data. Processing and analyzing large amounts…
DetailsDENVER–(BUSINESS WIRE)–Leafbuyer Technologies, Inc. (LBUY) (“Leafbuyer” or “the Company”), a leading cannabis technology company, announced today that annual revenue rose 59% in the fiscal year ending June 30, 2019. The increase reflects the revenue booked in the year versus the previous year. “We have spent the last fiscal year optimizing our platforms to outpace our…
DetailsMONTREAL–(BUSINESS WIRE)–Today Inversago Pharma Inc., a preclinical-stage biotech company developing new CB1 blockers for the treatment of targeted metabolic disorders, announced the appointment of Dr. Caroline Fradette as Vice-President, Clinical Research. “Over its first year of operations, Inversago has steadily progressed its programs towards the clinic”, highlighted François Ravenelle, PhD, CEO of the Company. “As…
DetailsRICHMOND, Va.–(BUSINESS WIRE)–Altria Group, Inc. (Altria) (NYSE:MO) today announced that merger discussions with Philip Morris International Inc. (PMI) (NYSE:PM) have ended. “While we believed the creation of a new merged company had the potential to create incremental revenue and cost synergies, we could not reach agreement,” said Howard Willard, Altria’s Chairman and Chief Executive Officer.…
Details